| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| B Limberg, B Kommerel. Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin. Gut. vol 25. issue 11. 1984-12-31. PMID:6149982. |
it is therefore suggested that the effect of somatostatin on the plasma amino acids may be because of the reduction of insulin and glucagon concentrations; however, other effects of somatostatin cannot be excluded at present. |
1984-12-31 |
2023-08-12 |
Not clear |
| K H Vogelberg, H J Müller, A Hübinge. [The somatostatin infusion test for the evaluation of glucose utilization in bezafibrate medication]. Arzneimittel-Forschung. vol 34. issue 9. 1984-12-27. PMID:6150716. |
the results show that the infusion test of somatostatin is fitted to measure a steady state of blood glucose and insulin and that it is possible by this technique to quantify a changed utilisation of blood glucose induced by specific therapy. |
1984-12-27 |
2023-08-12 |
Not clear |
| M D Meglasson, R L Hazelwoo. Adrenergic regulation of insulin secretion from the chicken pancreas in vitro. General and comparative endocrinology. vol 56. issue 1. 1984-12-20. PMID:6386599. |
inhibition of insulin secretion by somatostatin could be demonstrated, however. |
1984-12-20 |
2023-08-12 |
chicken |
| J H Shaw, R R Wolf. Energy and substrate kinetics and oxidation during ketone infusion in septic dogs: role of changes in insulin and glucagon. Circulatory shock. vol 14. issue 1. 1984-12-19. PMID:6149025. |
in both the septic and control groups, experiments were performed in which hormone levels were allowed to change in response to the bohb infusion, and in which the infusion of somatostatin, insulin, and glucagon were used to hold those hormone levels constant and sympathetic activity was blocked by the infusion of propranolol and phentolamine. |
1984-12-19 |
2023-08-12 |
Not clear |
| T R Russell, J Noel, N Files, M Ingram, A Rabinovitc. Purification of beta cells from rat islets by monoclonal antibody-fluorescence flow cytometry. Cytometry. vol 5. issue 5. 1984-12-19. PMID:6386391. |
sorted cell populations were analyzed by radioimmunoassay for insulin, glucagon, and somatostatin. |
1984-12-19 |
2023-08-12 |
rat |
| V E Gould, V A Memoli, L E Dardi, N S Goul. Nesidiodysplasia and nesidioblastosis of infancy: structural and functional correlations with the syndrome of hyperinsulinemic hypoglycemia. Pediatric pathology. vol 1. issue 1. 1984-12-06. PMID:6149528. |
specimens were studied by electron and conventional light microscopy and by light microscopic immunohistochemistry for insulin, glucagon, somatostatin, and hpp (human pancreatic polypeptide); double staining and quantitative methods were also used. |
1984-12-06 |
2023-08-12 |
human |
| R L Sorenson, C A Sasek, R P Eld. Phe-met-arg-phe-amide (FMRF-NH2) inhibits insulin and somatostatin secretion and anti-FMRF-NH2 sera detects pancreatic polypeptide cells in the rat islet. Peptides. vol 5. issue 4. 1984-12-05. PMID:6149524. |
phe-met-arg-phe-amide (fmrf-nh2) inhibits insulin and somatostatin secretion and anti-fmrf-nh2 sera detects pancreatic polypeptide cells in the rat islet. |
1984-12-05 |
2023-08-12 |
rat |
| R L Sorenson, C A Sasek, R P Eld. Phe-met-arg-phe-amide (FMRF-NH2) inhibits insulin and somatostatin secretion and anti-FMRF-NH2 sera detects pancreatic polypeptide cells in the rat islet. Peptides. vol 5. issue 4. 1984-12-05. PMID:6149524. |
fmrf-nh2 was investigated with regard to its effect on insulin, somatostatin and glucagon secretion from the isolated perfused rat pancreas. |
1984-12-05 |
2023-08-12 |
rat |
| R L Sorenson, C A Sasek, R P Eld. Phe-met-arg-phe-amide (FMRF-NH2) inhibits insulin and somatostatin secretion and anti-FMRF-NH2 sera detects pancreatic polypeptide cells in the rat islet. Peptides. vol 5. issue 4. 1984-12-05. PMID:6149524. |
fmrf-nh2 (1 microm) significantly inhibited glucose stimulated (300 mg/dl) insulin release (p less than 0.005) and somatostatin release (p less than 0.01) from the isolated perfused pancreas. |
1984-12-05 |
2023-08-12 |
rat |
| J Mössner, C D Logsdon, N Potau, J A Williams, I D Goldfin. Effect of intracellular Ca2+ on insulin-like growth factor II. internalization into pancreatic acini. Roles of insulin and cholecystokinin. The Journal of biological chemistry. vol 259. issue 20. 1984-11-30. PMID:6092332. |
we now report that the binding of 125i-labeled igf ii to mouse pancreatic acini is maximally increased by 100 nm insulin (51%) and is maximally reduced by 10 nm cholecystokinin octapeptide (cck8) (34%), but is not affected by other regulatory peptides such as somatostatin or glucagon. |
1984-11-30 |
2023-08-12 |
mouse |
| P J Dun. Pancreatic endocrine tissue in benign mediastinal teratoma. Journal of clinical pathology. vol 37. issue 10. 1984-11-30. PMID:6149236. |
the different pancreatic endocrine cell types were stained using antibodies to insulin, glucagon, somatostatin, and pancreatic polypeptide, and the volume density of each cell type was estimated by point counting. |
1984-11-30 |
2023-08-12 |
Not clear |
| M R Lucey, P D Fairclough, J A Wass, P Kwasowski, S Medbak, J Webb, L H Ree. Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man. Clinical endocrinology. vol 21. issue 3. 1984-11-19. PMID:6148162. |
response of circulating somatostatin, insulin, gastrin and gip, to intraduodenal infusion of nutrients in normal man. |
1984-11-19 |
2023-08-12 |
human |
| M R Lucey, P D Fairclough, J A Wass, P Kwasowski, S Medbak, J Webb, L H Ree. Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man. Clinical endocrinology. vol 21. issue 3. 1984-11-19. PMID:6148162. |
we have studied the effect of direct infusion of nutrients into the duodenum of normal subjects on circulating plasma somatostatin, insulin, gastrin and gastric inhibitory polypeptide (gip) levels. |
1984-11-19 |
2023-08-12 |
human |
| P M Radosevich, P E Williams, D B Lacy, J R McRae, K E Steiner, A D Cherrington, W W Lacy, N N Abumra. Effects of morphine on glucose homeostasis in the conscious dog. The Journal of clinical investigation. vol 74. issue 4. 1984-11-09. PMID:6148357. |
we also examined the effect of low dose morphine on glucose kinetics independent of changes in the endocrine pancreas by the use of somatostatin plus intraportal replacement of basal insulin and glucagon. |
1984-11-09 |
2023-08-12 |
dog |
| D J Evans, R Murray, A H Kisseba. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography. The Journal of clinical investigation. vol 74. issue 4. 1984-11-09. PMID:6148358. |
the increase in percentage of synthase i in response to submaximal steady state plasma insulin (sspi) of approximately 100 microu/ml achieved by the infusion of somatostatin, insulin, and glucose, however, was significantly lower in obese than in nonobese subjects, and was inversely correlated with whr. |
1984-11-09 |
2023-08-12 |
human |
| N Lytras, A Grossman, L H Rees, A V Schally, S R Bloom, G M Besse. Corticotrophin releasing factor: effects on circulating gut and pancreatic peptides in man. Clinical endocrinology. vol 20. issue 6. 1984-10-25. PMID:6147213. |
there was a significant rise in pancreatic polypeptide compared to a control infusion, but no change in plasma insulin, pancreatic glucagon, gastrin, somatostatin, motilin, neurotensin, gastric inhibitory peptide, or cholecystokinin was seen. |
1984-10-25 |
2023-08-12 |
human |
| E J Barrett, R G Schwartz, C K Francis, B L Zare. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. The Journal of clinical investigation. vol 74. issue 3. 1984-10-24. PMID:6381537. |
to assess the effect of physiological elevations of plasma insulin upon myocardial glucose and ffa uptake in vivo independent of changes in plasma substrate concentration, we measured arterial and coronary sinus concentrations of glucose, lactate, and ffa, and coronary blood flow in conscious dogs during a 30 min basal and a 2 h experimental period employing three protocols: (a) euglycemic hyperinsulinemia (insulin clamp, n = 5), (b) euglycemic hyperinsulinemia with ffa replacement (n = 5), (c) hyperglycemic euinsulinemia (hyperglycemic clamp with somatostatin, n = 5). |
1984-10-24 |
2023-08-12 |
dog |
| E J Barrett, R G Schwartz, C K Francis, B L Zare. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. The Journal of clinical investigation. vol 74. issue 3. 1984-10-24. PMID:6381537. |
hyperglycemia (plasma glucose = 186 +/- 8 mg/100 ml) during somatostatin infusion resulted in only a small rise in plasma insulin (delta = 12 +/- 7 microu/ml), and although plasma ffa tended to decline, heart glucose uptake did not rise significantly (delta = 5.5 +/- 3.2 mumol/min, p = ns). |
1984-10-24 |
2023-08-12 |
dog |
| P G Burhol, I Lygren, T G Jenssen, J Florholmen, R Jord. Somatostatin release and plasma molecular somatostatin components in man. Acta physiologica Scandinavica. vol 121. issue 3. 1984-10-24. PMID:6433648. |
the present paper describes a sensitive, precise and specific radioimmunoassay method for measurements of plasma somatostatin; significant rises in plasma somatostatin following a test meal, intraduodenal infusion of fat and hcl, and intravenous injection of insulin; and separation of immunoreactive plasma somatostatin into two components probably representing bound and free molecular forms of somatostatin both in fasting and postprandial human plasmas. |
1984-10-24 |
2023-08-12 |
human |
| Y Yawata, K Yamatani, M Tominaga, I Ebitani, M Hara, H Sasak. Hyperglycemic effect of neurotensin. The Tohoku journal of experimental medicine. vol 143. issue 2. 1984-10-11. PMID:6147906. |
although blood levels of glucagon and insulin were greatly reduced and not elevated by neurotensin in the presence of somatostatin, the response of blood glucose to neurotensin was similar to that in the absence of somatostatin. |
1984-10-11 |
2023-08-12 |
Not clear |